Journal of Applied Physiology, Vol 74, Issue 4 1704-1711, Copyright © 1993 by American Physiological Society

ARTICLES

Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed

T. J. McMahon, L. J. Ignarro and P. J. Kadowitz
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

The influence of Zaprinast (M&B 22948), a guanosine 3',5'-cyclic monophosphate (cGMP)-specific phosphodiesterase inhibitor, was investigated in the pulmonary vascular bed of the cat under conditions of controlled blood flow and constant left atrial pressure. Under baseline conditions, injections of Zaprinast into the perfused lobar artery produced small decreases in lobar arterial pressure without altering systemic arterial or left atrial pressure. When tone was increased with U-46619, Zaprinast caused larger dose-dependent decreases in lobar arterial pressure without altering left atrial pressure. The decreases in lobar arterial pressure were reduced significantly by treatment with the nitric oxide (NO) synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) or the guanylate cyclase inhibitor methylene blue. Under elevated tone conditions, efferent vagal stimulation and intralobar injections of acetylcholine, substance P, NO solution, and the S-nitrosothiols [S-nitroso-N-acetylpenicillamine (SNAP) and S-nitroso-L-cysteine (CysNO)] decreased lobar arterial pressure in a frequency-dependent and dose-related manner. After treatment with Zaprinast, the decreases in lobar arterial pressure in response to efferent vagal stimulation, the endothelium-dependent vasodilators, and the nitrovasodilators were not changed, whereas the duration of the vasodilator responses as measured by the half times was increased significantly. Vasodilator responses to adenosine, albuterol, and pinacidil were not altered by Zaprinast. These data suggest that cGMP hydrolysis in the lung is rapid and that endothelium-derived NO is important in stimulating basal cGMP production and in regulating vascular tone.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D J Fox and R S Khattar Pulmonary arterial hypertension: classification, diagnosis and contemporary management Postgrad. Med. J., November 1, 2006; 82(973): 717 - 722. [Full Text] [PDF]

				S. Jaillard, B. Larrue, P. Deruelle, A. Delelis, T. Rakza, G. Butrous, and L. Storme Effects of Phosphodiesterase 5 Inhibitor on Pulmonary Vascular Reactivity in the Fetal Lamb. Ann. Thorac. Surg., March 1, 2006; 81(3): 935 - 942. [Abstract] [Full Text] [PDF]

				D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF]

				I. Matot and Y. Gozal Pulmonary Responses to Selective Phosphodiesterase-5 and Phosphodiesterase-3 Inhibitors Chest, February 1, 2004; 125(2): 644 - 651. [Abstract] [Full Text] [PDF]

				B. J. De Witt, I. N. Ibrahim, E. Bayer, A. M. Fields, T. A. Richards, R. E. Banister, and A. D. Kaye An Analysis of Responses to Levosimendan in the Pulmonary Vascular Bed of the Cat Anesth. Analg., June 1, 2002; 94(6): 1427 - 1433. [Abstract] [Full Text] [PDF]

				L. Zhao, N. A. Mason, N. W. Morrell, B. Kojonazarov, A. Sadykov, A. Maripov, M. M. Mirrakhimov, A. Aldashev, and M. R. Wilkins Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension Circulation, July 24, 2001; 104(4): 424 - 428. [Abstract] [Full Text] [PDF]

				R. F. Lodato Viagra for Impotence of Pulmonary Vasodilator Therapy? Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 312 - 313. [Full Text]

				R. C. DUKARM, J. A. RUSSELL, F. C. MORIN III, B. J. PERRY, and R. H. STEINHORN The cGMP-specific Phosphodiesterase Inhibitor E4021 Dilates the Pulmonary Circulation Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 858 - 865. [Abstract] [Full Text]

				J. Bauer, C. Dau, A. Cavarape, F. Schaefer, H. Ehmke, and N. Parekh ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H1 - H7. [Abstract] [Full Text] [PDF]

				I. V. Turko, S. A. Ballard, S. H. Francis, and J. D. Corbin Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related Compounds Mol. Pharmacol., July 1, 1999; 56(1): 124 - 130. [Abstract] [Full Text]

				F. HINDER, H. D. STUBBE, H. VAN AKEN, R. WAURICK, M. BOOKE, and J. MEYER Role of Nitric Oxide in Sepsis-associated Pulmonary Edema Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 252 - 257. [Abstract] [Full Text]

				J. W. ZIEGLER, D. D. IVY, J. W. WIGGINS, J. P. KINSELLA, W. R. CLARKE, and S. H. ABMAN Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary Hypertension Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1388 - 1395. [Abstract] [Full Text] [PDF]

				J. W. ZIEGLER, D. DUNBAR IVY, J. J. FOX, J. P. KINSELLA, W. R. CLARKE, and S. H. ABMAN Dipyridamole Potentiates Pulmonary Vasodilation Induced by Acetylcholine and Nitric Oxide in the Ovine Fetus Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1104 - 1110. [Abstract] [Full Text] [PDF]

				S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]

				C. Adrie, F. Ichinose, A. Holzmann, L. Keefer, W. E. Hurford, and W. M. Zapol Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension J Appl Physiol, February 1, 1998; 84(2): 435 - 441. [Abstract] [Full Text] [PDF]

				Y. Naka, N. C. Chowdhury, H. Liao, D. K. Roy, M. C. Oz, R. E. Michler, and D. J. Pinsky Enhanced Preservation of Orthotopically Transplanted Rat Lungs by Nitroglycerin but Not Hydralazine : Requirement for Graft Vascular Homeostasis Beyond Harvest Vasodilation Circ. Res., May 1, 1995; 76(5): 900 - 906. [Abstract] [Full Text]